MWNA
GRNA

Marshall Wace North America’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Marshall Wace North America’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$4.54M Hold
458,576
– – 0.02% 538
2021
Q2 		$4.5M Hold
458,576
– – 0.02% 578
2021
Q1 		$4.44M Buy
+458,576
New +$4.5M 0.02% 606

Other funds holding GRNA

HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.62% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
OPU
Omni Partners US Irvine, California $1.95B AUM
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Marshall Wace North America's GRNA Position: Q3 2021 in Review

Marshall Wace North America held its GreenLight Biosciences Holdings, PBC Common Stock (GRNA) position steady in Q3 2021 at 458,576 shares worth $4.54M. The position accounts for 0.02% of the portfolio, ranked #538.

Marshall Wace North America first reported a position in GRNA in Q1 2021 and has held it in 3 quarters since. 70 funds tracked by Wall St. Rank hold GRNA as of Q3 2021.

  • Marshall Wace North America held 458,576 shares of GreenLight Biosciences Holdings, PBC Common Stock worth $4.54M as of Q3 2021.
  • Marshall Wace North America left its GreenLight Biosciences Holdings, PBC Common Stock share count unchanged in Q3 2021.
  • GreenLight Biosciences Holdings, PBC Common Stock made up 0.02% of Marshall Wace North America's portfolio in Q3 2021, its #538 holding.
  • Marshall Wace North America first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q1 2021 and has held it in 3 quarters since.
  • 70 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.